Yamamoto-Furusho JK - Search Results

1

Update of the PANCCO clinical practice guidelines for the treatment of ulcerative colitis in the adult population.

Juliao-Baños F, Grillo-Ardila CF, Alfaro I, Andara-Ramírez MT, Avelar-Escobar O, Barahona-Garrido J, Bautista-Martínez S, Bosques-Padilla FJ, De Paula JA, Ernest-Suárez K, Galiano MT, Iade-Vergara B, Patricio-Ibañez, Jara-Alba ML, Kotze PG, Miranda-Ojeda MC, Ortuño-Escalante R, Otoya-Moreno G, Piñol-Jiménez FN, Ramos-Polo IC, Sambuelli A, Toro M, Torres EA, Veitia-Velásquez GR, Yamamoto-Furusho JK, Zaltman C, Steinwurz F, Vallejo-Ortega M, Torres-Castillo JI, Hamon-Pinilla C, Calderon-Franco CH, Escobar-Villegas AM; Developer group. Juliao-Baños F, et al. Among authors: yamamoto furusho jk. Rev Gastroenterol Mex (Engl Ed). 2022 Jul-Sep;87(3):342-361. doi: 10.1016/j.rgmxen.2022.04.006. Epub 2022 Jul 22. Rev Gastroenterol Mex (Engl Ed). 2022. PMID: 35879225 Free article. Review.

2

[Immunogenetics of chronic ulcerative colitis].

Yamamoto-Furusho JK. Yamamoto-Furusho JK. Rev Invest Clin. 2003 Nov-Dec;55(6):705-10. Rev Invest Clin. 2003. PMID: 15011740 Review. Spanish.

3

Basic and clinical aspects of osteoporosis in inflammatory bowel disease.

Rodríguez-Bores L, Barahona-Garrido J, Yamamoto-Furusho JK. Rodríguez-Bores L, et al. World J Gastroenterol. 2007 Dec 14;13(46):6156-65. doi: 10.3748/wjg.v13.i46.6156. World J Gastroenterol. 2007. PMID: 18069754 Free PMC article. Review.

4

Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.

Yamamoto-Furusho JK, Uzcanga LF. Yamamoto-Furusho JK, et al. Dig Surg. 2008;25(5):383-6. doi: 10.1159/000170882. Epub 2008 Nov 13. Dig Surg. 2008. PMID: 19005257

5

Clinical epidemiology of ulcerative colitis in Mexico: a single hospital-based study in a 20-year period (1987-2006).

Yamamoto-Furusho JK. Yamamoto-Furusho JK. J Clin Gastroenterol. 2009 Mar;43(3):221-4. doi: 10.1097/MCG.0b013e31817a76b4. J Clin Gastroenterol. 2009. PMID: 19057395

6

Antinuclear antibodies: a marker associated with steroid dependence in patients with ulcerative colitis.

Barahona-Garrido J, Camacho-Escobedo J, García-Martínez CI, Tocay H, Cabiedes J, Yamamoto-Furusho JK. Barahona-Garrido J, et al. Inflamm Bowel Dis. 2009 Jul;15(7):1039-43. doi: 10.1002/ibd.20852. Inflamm Bowel Dis. 2009. PMID: 19107779

7

Growth factors as treatment for inflammatory bowel disease: a concise review of the evidence toward their potential clinical utility.

Barahona-Garrido J, Hernández-Calleros J, García-Juárez I, Yamamoto-Furusho JK. Barahona-Garrido J, et al. Saudi J Gastroenterol. 2009 Jul-Sep;15(3):208-12. doi: 10.4103/1319-3767.54742. Saudi J Gastroenterol. 2009. PMID: 19636186 Free PMC article. Review.

8

New treatment options in the management of IBD - focus on colony stimulating factors.

Barahona-Garrido J, Yamamoto-Furusho JK. Barahona-Garrido J, et al. Biologics. 2008 Sep;2(3):501-4. doi: 10.2147/btt.s3543. Biologics. 2008. PMID: 19707380 Free PMC article.

9

Serological markers in inflammatory bowel disease: a review of their clinical utility.

Barahona-Garrido J, Sarti HM, Barahona-Garrido MK, Hernández-Calleros J, Coss-Adame E, Garcia-Saenz SM, Yamamoto-Furusho JK. Barahona-Garrido J, et al. Rev Gastroenterol Mex. 2009;74(3):230-7. Rev Gastroenterol Mex. 2009. PMID: 19858012 Review.

10

[Mexican consensus on the use of agents anti-TNF-alpha in the treatment of inflammatory bowel disease.].

Yamamoto-Furusho JK, Bosques-Padilla F; Grupo mexicano de Consenso del uso de agentes anti-TNF-α en EII. Yamamoto-Furusho JK, et al. Rev Gastroenterol Mex. 2009;74(3):263-78. Rev Gastroenterol Mex. 2009. PMID: 19858021 Review. Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

172 results

Search Page